Biological reprogramming in acquired resistance to endocrine therapy of breast cancer. (Q39667297)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20711236 AND SRC:MED&resulttype=core&format=json

10 February 2020

title

Biological reprogramming in acquired resistance to endocrine therapy of breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20711236 AND SRC:MED&resulttype=core&format=json

10 February 2020

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20711236 AND SRC:MED&resulttype=core&format=json

10 February 2020

Xavier Solé

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20711236 AND SRC:MED&resulttype=core&format=json

10 February 2020

Nuria Bonifaci

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20711236 AND SRC:MED&resulttype=core&format=json

10 February 2020

Ander Urruticoechea

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20711236 AND SRC:MED&resulttype=core&format=json

10 February 2020

author name string

H Aguilar

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20711236 AND SRC:MED&resulttype=core&format=json

10 February 2020

J Serra-Musach

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20711236 AND SRC:MED&resulttype=core&format=json

10 February 2020

A Islam

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20711236 AND SRC:MED&resulttype=core&format=json

10 February 2020

M Méndez-Pertuz

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20711236 AND SRC:MED&resulttype=core&format=json

10 February 2020

R L Beijersbergen

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20711236 AND SRC:MED&resulttype=core&format=json

10 February 2020

C Lázaro

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20711236 AND SRC:MED&resulttype=core&format=json

10 February 2020

M A Pujana

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20711236 AND SRC:MED&resulttype=core&format=json

10 February 2020

language of work or name

English

0 references

publication date

16 August 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20711236 AND SRC:MED&resulttype=core&format=json

10 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20711236 AND SRC:MED&resulttype=core&format=json

10 February 2020

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20711236 AND SRC:MED&resulttype=core&format=json

10 February 2020

issue

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20711236 AND SRC:MED&resulttype=core&format=json

10 February 2020

page(s)

6071-6083

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20711236 AND SRC:MED&resulttype=core&format=json

Genetic regulators of large-scale transcriptional signatures in cancer

10 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Genetic screen identifies insulin-like growth factor binding protein 5 as a modulator of tamoxifen resistance in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Correlating measurements across samples improves accuracy of large-scale expression profile experiments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Pocket protein complexes are recruited to distinct targets in quiescent and proliferating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Phase II randomized study of neoadjuvant everolimus plus letrozole compared with placebo plus letrozole in patients with estrogen receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Akt-induced endocrine therapy resistance is reversed by inhibition of mTOR signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

interferon regulatory factor-1 mediates the proapoptotic but not cell cycle arrest effects of the steroidal antiestrogen ICI 182,780 (faslodex, fulvestrant).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Interferon-regulatory factor-1 is critical for tamoxifen-mediated apoptosis in human mammary epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

ESR1 gene amplification in breast cancer: a common phenomenon?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

JASPAR, the open access database of transcription factor-binding profiles: new content and tools in the 2008 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Genome-wide analysis of estrogen receptor binding sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Molecular changes associated with the acquisition of oestrogen hypersensitivity in MCF-7 breast cancer cells on long-term oestrogen deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

GATHER: a systems approach to interpreting genomic signatures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Double-blind, randomized placebo controlled trial of fulvestrant compared with exemestane after prior nonsteroidal aromatase inhibitor therapy in postmenopausal women with hormone receptor-positive, advanced breast cancer: results from EFECT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

American Society of Clinical Oncology technology assessment of pharmacologic interventions for breast cancer risk reduction including tamoxifen, raloxifene, and aromatase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Targeting fibroblast growth factor receptors blocks PI3K/AKT signaling, induces apoptosis, and impairs mammary tumor outgrowth and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Mechanisms of resistance to aromatase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Biological characteristics of the pure antiestrogen fulvestrant: overcoming endocrine resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Genome-wide association study identifies novel breast cancer susceptibility loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Positive cross-regulatory loop ties GATA-3 to estrogen receptor alpha expression in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Zfx controls the self-renewal of embryonic and hematopoietic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

affy--analysis of Affymetrix GeneChip data at the probe level

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Influence of letrozole and anastrozole on total body aromatization and plasma estrogen levels in postmenopausal breast cancer patients evaluated in a randomized, cross-over study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Bioconductor: open software development for computational biology and bioinformatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Endocrine resistance associated with activated ErbB system in breast cancer cells is reversed by inhibiting MAPK or PI3K/Akt signaling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Identification of CDK10 as an important determinant of resistance to endocrine therapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Activation of mitogen-activated protein kinase in xenografts and cells during prolonged treatment with aromatase inhibitor letrozole

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Estrogen receptor expression and function in long-term estrogen-deprived human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Lapatinib combined with letrozole versus letrozole and placebo as first-line therapy for postmenopausal hormone receptor-positive metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Aromatase inhibitors: combinations with fulvestrant or signal transduction inhibitors as a strategy to overcome endocrine resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Transcriptional regulation of human fibroblast growth factor receptor 1 by E2F-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Elevated levels of epidermal growth factor receptor/c-erbB2 heterodimers mediate an autocrine growth regulatory pathway in tamoxifen-resistant MCF-7 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

The role of fibroblast growth factors in tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

GATA-3 and the regulation of the mammary luminal cell fate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Estrogen receptor phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Overexpression of CEACAM6 promotes migration and invasion of oestrogen-deprived breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Elevated ERK1/ERK2/estrogen receptor cross-talk enhances estrogen-mediated signaling during long-term estrogen deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Enhanced estrogen receptor (ER) alpha, ERBB2, and MAPK signal transduction pathways operate during the adaptation of MCF-7 cells to long term estrogen deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Genome-wide analysis of aromatase inhibitor-resistant, tamoxifen-resistant, and long-term estrogen-deprived cells reveals a role for estrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Resistance to endocrine therapy in breast cancer: exploiting estrogen receptor/growth factor signaling crosstalk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Unraveling the mechanisms of endocrine resistance in breast cancer: new therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

TRANSFAC and its module TRANSCompel: transcriptional gene regulation in eukaryotes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Allele-specific up-regulation of FGFR2 increases susceptibility to breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Tamoxifen resistance by a conformational arrest of the estrogen receptor alpha after PKA activation in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Changes in breast cancer transcriptional profiles after treatment with the aromatase inhibitor, letrozole

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Sparse representation and Bayesian detection of genome copy number alterations from microarray data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

An open randomised trial of second-line endocrine therapy in advanced breast cancer. comparison of the aromatase inhibitors letrozole and anastrozole

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

The role of growth factor receptor pathways in human breast cancer cells adapted to long-term estrogen deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Use of global gene expression patterns in mechanistic studies of oestrogen action in MCF7 human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Adaptive hypersensitivity to estradiol: potential mechanism for secondary hormonal responses in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Long-term estradiol deprivation in breast cancer cells up-regulates growth factor signaling and enhances estrogen sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Tamoxifen induces expression of immune response-related genes in cultured normal human mammary epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Statistical significance of cis-regulatory modules

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Changes in oestrogen receptor-alpha and -beta during progression to acquired resistance to tamoxifen and fulvestrant (Faslodex, ICI 182,780) in MCF7 human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Pathway analysis reveals functional convergence of gene expression profiles in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Estradiol hypersensitivity and mitogen-activated protein kinase expression in long-term estrogen deprived human breast cancer cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Biological convergence of cancer signatures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Role of receptor complexes in the extranuclear actions of estrogen receptor alpha in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

ASD: a bioinformatics resource on alternative splicing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Loss of growth inhibitory effects of retinoic acid in human breast cancer cells following long-term exposure to retinoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Insulin-like growth factor receptor levels are regulated by cell density and by long term estrogen deprivation in MCF7 human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Regulation of FGF receptor-2 expression by transcription factor E2F-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Estrogen receptor alpha gene ESR1 amplification may predict endocrine therapy responsiveness in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

A gene-expression signature as a predictor of survival in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Low E2F1 transcript levels are a strong determinant of favorable breast cancer outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Adaptation of estrogen-dependent MCF-7 cells to low estrogen (phenol red-free) culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive breast cancer: status report 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

MYC regulation of a "poor-prognosis" metastatic cancer cell state

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

A comprehensive ChIP-chip analysis of E2F1, E2F4, and E2F6 in normal and tumor cells reveals interchangeable roles of E2F family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Pathway analysis of gene signatures predicting metastasis of node-negative primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Farnesylthiosalicylic acid blocks mammalian target of rapamycin signaling in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Adaptive hypersensitivity following long-term estrogen deprivation: involvement of multiple signal pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Integrated analysis of independent gene expression microarray datasets improves the predictability of breast cancer outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

A randomised study to compare the effect of the luteinising hormone releasing hormone (LHRH) analogue goserelin with or without tamoxifen in pre- and perimenopausal patients with advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Absence of ESR1 amplification in a series of breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Estrogen-independent proliferation is present in estrogen-receptor HER2-positive primary breast cancer after neoadjuvant letrozole

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

GATA-3 is expressed in association with estrogen receptor in breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

ESR1 gene amplification in breast cancer: a common phenomenon?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Enhanced epidermal growth factor receptor signaling in MCF7 breast cancer cells after long-term culture in the presence of the pure antiestrogen ICI 182,780 (Faslodex).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

ESR1 gene amplification in breast cancer: a common phenomenon?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

Adaptation to estradiol deprivation causes up-regulation of growth factor pathways and hypersensitivity to estradiol in breast cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333

ESR1 gene amplification in breast cancer: a common phenomenon?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.333